Ignite Creation Date:
2025-12-25 @ 1:27 AM
Ignite Modification Date:
2025-12-27 @ 11:15 PM
Study NCT ID:
NCT04367194
Status:
COMPLETED
Last Update Posted:
2021-01-14
First Post:
2020-04-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Objective Examination and Rehabilitation Treatment of Patients With BPPV
Sponsor:
Somogy Megyei Kaposi Mór Teaching Hospital
Organization:
Study Overview
Official Title:
Objective Examination and Rehabilitation Treatment of Patients With BPPV
Status:
COMPLETED
Status Verified Date:
2021-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Dizziness (BPPV) causes severe deterioration in quality of life, incoordination, and instability.
In the study, we selected a minimum of 100 patients with BPPV who were examined after specialist care. After the acute phase, a physical survey is performed where movement and coordination are examined.
After the results, the patients undergo a rehabilitation training. The workout is submaximal and high intensity that is done for 3 weeks.
Hypothesis: As a result of training, it is possible that the remaining feeling of dizziness and insecurity, impaired coordination will decrease or disappear.
In the study, we selected a minimum of 100 patients with BPPV who were examined after specialist care. After the acute phase, a physical survey is performed where movement and coordination are examined.
After the results, the patients undergo a rehabilitation training. The workout is submaximal and high intensity that is done for 3 weeks.
Hypothesis: As a result of training, it is possible that the remaining feeling of dizziness and insecurity, impaired coordination will decrease or disappear.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: